相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oncostatin M promotes hepatic progenitor cell activation and hepatocarcinogenesis via macrophage-derived tumor necrosis factor-α
Xue Yang et al.
CANCER LETTERS (2021)
Prognostic factors for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: a multicenter study in China
Haitao Shang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Quantitative CT assessment by histogram and volume ratio in pyrrolizidines alkaloids-induced hepatic sinusoidal obstruction syndrome
Xiaoqian Yang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2021)
Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study
Fang Liu et al.
BMC GASTROENTEROLOGY (2020)
Clinical efficacy and safety of anticoagulation therapy for Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective multicenter cohort study
Chunyan Peng et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2020)
Myofibroblast induces hepatocyte-to-ductal metaplasia via laminin-?vβ6 integrin in liver fibrosis
Ting Xu et al.
CELL DEATH & DISEASE (2020)
Seneciphylline, a main pyrrolizidine alkaloid inGynura japonica, induces hepatotoxicity in mice and primary hepatocytes via activating mitochondria-mediated apoptosis
Weiqian Wang et al.
JOURNAL OF APPLIED TOXICOLOGY (2020)
Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome
Yuzheng Zhuge et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function
Tingting Guo et al.
SCIENTIFIC REPORTS (2019)
Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes
Xiao-Qian Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Oncostatin M, an Underestimated Player in the Central Nervous System
Evelien Houben et al.
FRONTIERS IN IMMUNOLOGY (2019)
Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice
Michitaka Matsuda et al.
HEPATOLOGY (2018)
Interleukin-6 Family Cytokines
Stefan Rose-John
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease
Yu Z. Zhuge et al.
LIVER INTERNATIONAL (2018)
Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study
Yan Wang et al.
BMC GASTROENTEROLOGY (2018)
Inhibition of Drp1 protects against senecionine-induced mitochondria-mediated apoptosis in primary hepatocytes and in mice
Xiao Yang et al.
REDOX BIOLOGY (2017)
Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications
Frederic Torossian et al.
JCI INSIGHT (2017)
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
M. Mohty et al.
BONE MARROW TRANSPLANTATION (2016)
Sinusoidal obstruction syndrome
Dominique-Charles Valla et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome
Xuefeng Kan et al.
SCIENTIFIC REPORTS (2016)
Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1
Kojiro Nakamura et al.
LIVER INTERNATIONAL (2014)
Sinusoidal Obstruction Syndrome (Hepatic Veno-Occlusive Disease)
Cathy Q. Fan et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2014)
Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9
Kojiro Nakamura et al.
JOURNAL OF HEPATOLOGY (2012)
Management of hepatic vascular diseases
Aurélie Plessier et al.
JOURNAL OF HEPATOLOGY (2012)
Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling
Pierre Guihard et al.
STEM CELLS (2012)
Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum
Ge Lin et al.
JOURNAL OF HEPATOLOGY (2011)
Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation
Stefan P. Kastl et al.
BLOOD (2009)
Vascular Disorders of the Liver
Laurie D. DeLeve et al.
HEPATOLOGY (2009)
Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats
Tetsuhiro Hamada et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Expression of oncostatin M and its receptors in normal and cirrhotic human liver
I Znoyko et al.
JOURNAL OF HEPATOLOGY (2005)
Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes
A Okaya et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice
K Nakamura et al.
HEPATOLOGY (2004)
Effects of ximelagatran, an oral direct thrombin inhibitor, r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects
TC Sarich et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Anticoagulants prevent monocrotaline-induced hepatic parenchymal cell injury but not endothelial cell injury in the rat
BL Copple et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2002)
Oncostatin M: a cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells
MT Levy et al.
JOURNAL OF HEPATOLOGY (2000)
分享论文
